Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DAWN

Day One Biopharmaceuticals Inc

Apr 22 • 04:00PM ET

21.53

0.00 0.00 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: VRTX NBIX BPMC SRPT EXEL FATE IGMS KURA BHVN PBYI

| Held by: VTI VB VXF VTWO VBR VBK VHT ARB VTWV EVNT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.04	Insider Own	27.17%	Shs Outstand	102.98M	Perf Week	0.19%
Market Cap	2.22B	Forward P/E	-	EPS next Y	-0.17	Insider Trans	-0.23%	Shs Float	75.26M	Perf Month	0.56%
Enterprise Value	1.79B	PEG	-	EPS next Q	-0.42	Inst Own	66.00%	Short Float	8.74%	Perf Quarter	74.61%
Income	-107.32M	P/S	14.06	EPS this Y	8.65%	Inst Trans	-10.28%	Short Ratio	1.66	Perf Half Y	187.45%
Sales	158.18M	P/B	5.03	EPS next Y	81.75%	ROA	-19.68%	Short Interest	6.58M	Perf YTD	131.01%
Book/sh	4.28	P/C	5.04	EPS next 5Y	-	ROE	-22.74%	52W High	21.53 0.00%	Perf Year	193.72%
Cash/sh	4.27	P/FCF	-	EPS past 3/5Y	21.77% -9.72%	ROIC	-24.18%	52W Low	5.64 282.08%	Perf 3Y	57.15%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	89.12%	Volatility	0.11% 0.16%	Perf 5Y	-
Dividend TTM	-	EV/Sales	11.29	EPS Y/Y TTM	-0.47%	Oper. Margin	-80.76%	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.91	Sales Y/Y TTM	20.60%	Profit Margin	-67.85%	RSI (14)	80.32	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.02	EPS Q/Q	68.21%	SMA20	0.36%	Beta	-1.65	Target Price	21.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	83.92%	SMA50	19.55%	Rel Volume	0.00	Prev Close	21.53
Employees	178	LT Debt/Eq	0.01	Earnings	Feb 24 AMC	SMA200	102.18%	Avg Volume	3.97M	Price	21.53
IPO	May 27, 2021	Option/Short	Yes / No	EPS/Sales Surpr.	-41.03% 7.75%	Trades		Volume	0	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)